According to the terms of the agreement, Sanofi will acquire London-based Vicebio’s entire share capital for an upfront ...

Sanofi has signed an agreement to acquire Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities.

A campaign backed by Kyowa Kirin, Amgen and Sanofi is calling on prominent organizations with medical websites to bring their ...

The mercury-based preservative thimerosal will be removed from all flu shots distributed in United States, Health and Human ...

“Vicebio’s Molecular Clamp technology introduces a purposefully simple but thoughtful approach to further improve vaccine ...

(Reuters) -The United States will stop distributing all influenza vaccines that contain mercury-based preservative thimerosal ...

Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...

The decision follows last month’s vote of the CDC’s revamped vaccine advisory committee. Thimerosal, mostly removed from vaccines decades ago, has long been a target of anti-vaccine advocates for ...

While few shots still contain thimerosal, the move eliminates a vaccine option for Americans and is a win for the ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. A visit to the chiropractor can provide many health benefits.

Aventis Energy ('Aventis” or the 'Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is pleased to provide a summary of results from an airborne Time Domain Electromagnetic ('TDEM”) survey (the 'Program”) ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...